Allen Capital Group, LLC Abbott Laboratories Transaction History

Allen Capital Group, LLC

$855 Million
Q3 2024

A detailed history of Allen Capital Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Allen Capital Group, LLC holds 4,701 shares of ABT stock, worth $555,329. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,701

Previous 4,230 11.13%

Holding current value

$555,329

Previous $439,000 21.87%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $47,132 - $55,639	471 Added 11.13%	4,701 $535,000
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $7,856 - $8,770	-78 Reduced 1.81%	4,230 $439,000
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $37,127 - $41,005	339 Added 8.54%	4,308 $489,000
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $50,686 - $62,044	562 Added 16.5%	3,969 $436,000
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $13,278 - $15,932	-139 Reduced 3.92%	3,407 $329,000
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $25,195 - $28,072	250 Added 7.58%	3,546 $386,000
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $319,250 - $375,776	3,296 New	3,296 $333,000
Q2 2022 Jul 27, 2022	BUY	$102.07 - $123.37 $34,091 - $41,205	334 Added 11.29%	3,292 $358,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $114 - $139	1 Added 0.03%	2,958 $350,000
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $341,622 - $418,297	2,957 New	2,957 $416,000
Q4 2021 Jan 25, 2022	SELL	$115.53 - $141.46 $341,506 - $418,155	-2,956 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $4,199 - $4,646	36 Added 1.23%	2,956 $349,000
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $22,215 - $26,151	210 Added 7.75%	2,920 $339,000
Q1 2020 Apr 15, 2020	SELL	$62.82 - $91.86 $9,737 - $14,238	-155 Reduced 5.41%	2,710 $214,000
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $2,276 - $2,534	-29 Reduced 1.0%	2,865 $249,000
Q2 2019 Jul 22, 2019	SELL	$72.88 - $85.0 $323,514 - $377,315	-4,439 Reduced 60.53%	2,894 $243,000
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $58,803 - $71,093	-888 Reduced 10.8%	7,333 $586,000
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $16,717 - $18,938	255 Added 3.2%	8,221 $587,000
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $15,141 - $18,266	-249 Reduced 3.03%	7,966 $584,000
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $2,187 - $2,414	38 Added 0.46%	8,215 $501,000
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $40,233 - $45,488	715 Added 9.58%	8,177 $490,000
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $400,560 - $428,841	7,462	7,462 $426,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Capital Group, LLC with notifications on news.

Account

Allen Capital Group, LLC Abbott Laboratories Transaction History